Total Payments
$4,875
2024 Payments
$766.59
Companies
13
Transactions
73
Medicare Patients
9,634
Medicare Billing
$7.3M
Payment Breakdown by Category
Food & Beverage$2,347 (48.1%)
Travel$1,908 (39.1%)
Other$500.00 (10.3%)
Education$119.77 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,347 | 62 | 48.1% |
| Travel and Lodging | $1,908 | 7 | 39.1% |
| Grant | $500.00 | 1 | 10.3% |
| Education | $119.77 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,803 | 13 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $1,097 | 4 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $644.19 | 12 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $593.84 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $281.77 | 8 | $0 (2024) |
| Alimera Sciences, Inc. | $171.62 | 7 | $0 (2024) |
| Genentech USA, Inc. | $91.63 | 4 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $53.80 | 3 | $0 (2024) |
| ABBVIE INC. | $39.31 | 2 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $34.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $766.59 | 21 | Astellas Pharma US Inc ($218.79) |
| 2023 | $690.18 | 23 | Apellis Pharmaceuticals, Inc. ($261.54) |
| 2022 | $385.71 | 9 | Regeneron Healthcare Solutions, Inc. ($178.62) |
| 2021 | $16.90 | 1 | Regeneron Healthcare Solutions, Inc. ($16.90) |
| 2018 | $2,901 | 17 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,803) |
| 2017 | $115.42 | 2 | Regeneron Healthcare Solutions, Inc. ($87.92) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Ophthalmology | ||||||
| 09/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Ophthalmology | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: Ophthalmology | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/12/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Ophthalmology | ||||||
| 04/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $87.98 | General |
| Category: Ophthalmology | ||||||
| 04/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Ophthalmology | ||||||
| 03/08/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Ophthalmology | ||||||
| 02/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $123.58 | General |
| Category: Ophthalmology | ||||||
| 02/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: EYE CARE | ||||||
| 02/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Ophthalmology | ||||||
| 02/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/21/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | Cash or cash equivalent | $17.19 | General |
| Category: Ophthalmology | ||||||
| 11/03/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $31.09 | General |
| 10/10/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,680 | 14,893 | $4.1M | $915,543 |
| 2022 | 13 | 1,642 | 3,018 | $1.8M | $578,627 |
| 2021 | 24 | 3,562 | 12,387 | $7.8M | $3.4M |
| 2020 | 19 | 2,750 | 8,733 | $5.4M | $2.4M |
Total Patients
9,634
Total Services
39,031
Medicare Billing
$7.3M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 57 | 532 | $1.6M | $367,359 | 22.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 43 | 11,040 | $1.4M | $319,758 | 22.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 139 | 675 | $270,327 | $58,370 | 21.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 296 | 462 | $197,569 | $41,181 | 20.8% |
| 92134 | Imaging of retina | Office | 2023 | 472 | 1,247 | $169,806 | $36,533 | 21.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 260 | 260 | $131,708 | $27,159 | 20.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 17 | 17 | $64,237 | $14,668 | 22.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 76 | 265 | $67,129 | $14,533 | 21.6% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 15 | 15 | $56,512 | $12,997 | 23.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 78 | 79 | $36,628 | $8,399 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $22,742 | $4,634 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 34 | $14,517 | $2,910 | 20.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 81 | 145 | $12,048 | $2,487 | 20.6% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 14 | 14 | $12,492 | $2,441 | 19.5% |
| 92250 | Photography of the retina | Office | 2023 | 36 | 39 | $5,304 | $1,018 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $2,834 | $649.65 | 22.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 13 | $2,677 | $445.49 | 16.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 181 | 644 | $1.3M | $458,891 | 34.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 308 | 577 | $171,108 | $37,044 | 21.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 126 | 220 | $76,241 | $21,230 | 27.8% |
| 92134 | Imaging of retina | Office | 2022 | 455 | 808 | $70,546 | $18,781 | 26.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 144 | 144 | $56,066 | $15,400 | 27.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 146 | 297 | $64,401 | $13,766 | 21.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 55 | 56 | $16,382 | $4,915 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,862 | $2,107 | 30.7% |
About Dr. Ryan Vogel, MD
Dr. Ryan Vogel, MD is a Retina Specialist healthcare provider based in Greenfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1124361142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Vogel, MD has received a total of $4,875 in payments from pharmaceutical and medical device companies, with $766.59 received in 2024. These payments were reported across 73 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,347).
As a Medicare-enrolled provider, Vogel has provided services to 9,634 Medicare beneficiaries, totaling 39,031 services with total Medicare billing of $7.3M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Location Greenfield, WI
- Active Since 03/27/2013
- Last Updated 02/05/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1124361142
Products in Payments
- STELLARIS (Device) $1,803
- Syfovre (Drug) $443.09
- EYLEA (Biological) $336.72
- EYLEA HD (Biological) $219.55
- Izervay (Drug) $218.79
- ILUVIEN (Drug) $126.46
- Vabysmo (Drug) $91.63
- EYLEA AFLIBERCEPT INJECTION (Biological) $87.92
- XIPERE (Drug) $53.80
- YUTIQ (Drug) $45.16
- OZURDEX (Drug) $39.31
- PURIFIED CORTROPHIN GEL (Drug) $34.97
- AcrySof (Device) $27.50
- BYOOVIZ (Biological) $20.93
- Constellation (Device) $15.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.